Overview
A. Marisa Chun and Paul DeStefano led the McDermott team that represented South Korean biotechnology company PharmAbcine Inc. in its licensing agreement with Triphase Accelerator Corp. The agreement involved commercial rights for a compound related to the treatment of multiple forms of cancer.